Stockreport

Capricor Trial Failure In Heart Disease Might Offer Another Opportunity [Seeking Alpha]

Capricor Therapeutics, Inc.  (CAPR) 
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors
PDF Summary On Friday Capricor Therapeutics (NASDAQ: CAPR ) announced that it had failed a mid-stage trial using its cell therapy treatment on patients with heart at [Read more]